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Natural killer (NK) cells and CD8 T cells play a prominent role in the clearance of mouse cytomegalovirus (MCMV) infection.
The role of NK cells in modulating the CD8 T-cell response toMCMV infection is still the subject of intensive research. For
analyzing the impact of NK cells onmounting of a CD8 T-cell response and the contribution of these cells to virus control dur-
ing the first days postinfection (p.i.), we used C57BL/6 mice in which NK cells are specifically activated through the Ly49H recep-
tor engaged by theMCMV-encoded ligandm157. Our results indicate that the requirement for CD8 T cells in early MCMV
control inversely correlates with the engagement of Ly49H.While depletion of CD8 T cells has only a minor effect on the early
control of wild-typeMCMV, CD8 T cells are essential in the control ofm157 virus. The frequencies of virus epitope-specific
CD8 T cells and their activation status were higher in mice infected withm157 virus. In addition, these mice showed elevated
levels of alpha interferon (IFN-) and several other proinflammatory cytokines as early as 1.5 days p.i. Although the numbers of
conventional dendritic cells (cDCs) were reduced later during infection, particularly inm157-infected mice, they were not sig-
nificantly affected at the peak of the cytokine response. Altogether, we concluded that increased antigen load, preservation of
early cDCs’ function, and higher levels of innate cytokines collectively account for an enhanced CD8 T-cell response in
C57BL/6 mice infected with a virus unable to activate NK cells via the Ly49H–m157 interaction.
Mouse cytomegalovirus (MCMV)has been extensively used asamodel for studying the role ofNK cells in virus control. NK
cells play a crucial role in the early stage ofMCMV infection, prior
to the induction of the adaptive immune response (20). However,
the contribution of NK cells in the control of early MCMV infec-
tion varies amongmouse strains (38; reviewed in reference 43). In
C57BL/6 mice, the activating NK cell receptor Ly49H mediates
resistance toMCMV infection due to the specific binding ofm157,
a virally encoded protein (6, 46). NK cell activation through
Ly49H–m157 interaction is characterized by perforin-mediated
cytotoxicity and specific proliferation of Ly49HNK cells (13, 26,
49). Unlike C57BL/6 mice, MCMV-susceptible mouse strains are
unable to mount an effective NK cell response to this virus (re-
viewed in reference 42).
In addition to their direct function, which results in the con-
tainment of viral infection, a large body of accumulated data sug-
gests that NK cells play a role also in the shaping of the specific
immune response (reviewed in reference 50). However, this topic
is still controversial and the subject of intense studies. Robbins
and colleagues (40) have shown that NK cell activation via the
Ly49H–m157 pathway accelerates the CD8 T-cell response in
vivo. According to the proposed scenario, the activation of NK
cells via this axis limits alpha/beta interferon (IFN-/) produc-
tion by plasmacytoid dendritic cells (pDCs) and consequently
prevents depletion of splenic conventionalDCs (cDCs) and causes
a prompt induction of a CD8 T-cell response. However, An-
drews et al. (3) have shown that an NK cell response mediated
through Ly49H–m157 interaction limits the long-term efficacy of
specific CD8 and CD4 T cells and that this is a consequence of
an altered frequency and duration of infection of antigen-
presenting cells. More recently, Stadnisky and colleagues (47)
have demonstrated a role for inhibitoryNK receptors in theCD8
T-cell response to MCMV. Although these authors did not ex-
clude a role for MCMV-specific activating NK receptors in their
model, they provided first evidence to propose that the recogni-
tion of infected cells by licensed Ly49G2 NK cells results in a
faster recovery of splenic cDCs and an enhanced antigen-specific
CD8 T-cell response. In BALB/c mice, which do not express
Ly49H and thus constitutively lack NK cell activation through
Ly49H–m157 signaling, virus replication within the first 4 days
postinfection (p.i.) was not notably controlled by either NK cells
or CD8 T cells, unless deletion of viral immune evasion genes, of
genem152 in particular, attenuated virus replication by recruiting
NK cells and CD8 T cells due to elevated expression of the NK
cell-activating ligand RAE-1 and enhanced major histocompati-
bility complex class I (MHC-I) peptide presentation, respectively
(7). In addition, we have recently shown that recombinant virus
expressing activating NKG2D ligand RAE-1 is able to activate a
strong CD8 T-cell response in spite of a significant NK cell- and
NKG2D-dependent early attenuation (45).
In the present study, we have assessed the CD8 T-cell re-
sponse in C57BL/6mice during the first few days of infection with
wild-type (WT) MCMV able to engage the Ly49H receptor, or
withm157 virus, which fails to activateNK cells via this receptor.
In essence, our results have revealed that Ly49H–m157 signaling
drives the NK cell response, whereas the inability of virus control
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via NK cells in the absence of Ly49H–m157 signaling results in a
stronger CD8 T-cell response. Specifically, the data demonstrate
that NK cell engagement through the Ly49H–m157 interaction
limits the contribution of CD8 T cells to the control of MCMV.
In contrast, in Ly49H mice infected with m157 MCMV, the
CD8 T-cell response proved to be not only enhanced but also
indispensable for virus control. Notably, CD8 T cells became
essential even in the control of WTMCMV at high doses of infec-
tion. A more efficient CD8 T-cell response is most likely sup-
ported by elevated levels of proinflammatory cytokines able to
drive the expansion of antiviral CD8T cells. Altogether, our data
suggest that an increased antigen load available for CD8 T-cell
priming in concert with the preservation of cDCs’ function early
after infection and with elevated levels of proinflammatory cyto-
kines explains the enhancedCD8T-cell response inmice lacking
early NK cell antiviral control.
MATERIALS AND METHODS
Mice. Ly49H mice (C57BL/6, BALB.B6-Cmv1r) and Ly49H mice
(B6.Ly49h/ [15], BALB/c, and 129/SvJ) were housed and bred under
specific-pathogen-free conditions at the Central Animal Facility of the
Medical Faculty, University of Rijeka, in accordance with the guidelines
contained in the International Guiding Principles for Biomedical Research
Involving Animals. The Ethical Committee at the University of Rijeka
approved all animal experiments described in this paper. Eight- to 12-
week-old mice were used in all experiments.
Viruses.Unless otherwise indicated, mice were injected intravenously
(i.v.) with 2 105 PFU of the tissue culture (TC)-grown virus in a volume
of 500 l of diluents. Bacterial artificial chromosome (BAC)-derived
MCMV strain MW97.01 has previously been shown to be biologically
equivalent to MCMV strain Smith (VR-1399) and is hereafter referred to
as wild-type (WT) MCMV (51). MCMV recombinant virus expressing
green fluorescent protein (MCMV-GFP), a derivative of the MCMV
strain MW97.01, is hereafter referred to as WT MCMV-GFP (34). In
addition, the mutant virus m157 MCMV, which was previously de-
scribed (8), was used.
Depletion of lymphocyte subsets and quantitation of viral gene ex-
pression and infectivity. The depletion of NK cells in vivowas performed
by intraperitoneal (i.p.) injection of 300 g of purified monoclonal anti-
body (MAb) PK136 (23) 1 day before infection, which was repeated on
day 1 p.i. The depletion of theCD8T-lymphocyte subsetwas done by i.p.
injection of 300 g of MAb to CD8 (YTS 169.4) (10) on days 1 and 5 p.i.
The efficacy of depletion was assessed by flow cytometric analysis of
splenic leukocytes stained with allophycocyanin (APC)-labeled anti-
NK1.1 (eBioscience) and phycoerythrin (PE)-labeled anti-CD8 (BD
Pharmingen).
Viral transcription in draining popliteal lymph nodes (PLNs) was
measured by absolute quantitation of spliced IE1 transcripts using a real-
time one-step reverse transcription-PCR (RT-PCR) as described in
greater detail previously (7, 44). For quantitating viral infectivity in or-
gans, virus titers were determined by standard plaque assay, as described
previously (21).
Flow cytometry and enzyme-linked immunospot (ELISpot) assay.
Splenic leukocytes were prepared as previously described and, in order to
reduce nonspecific staining, Fc receptors were blocked with 2.4G2 MAbs
(54). The following Abs were purchased from eBioscience or BD Phar-
mingen, and cell surface staining was performed specifically for the fol-
lowing antigens: anti-CD3 (145-2C11), anti-NK1.1 (PK136), anti-
Ly49H (3D10), anti-CD69 (H1.2F3), anti-CD27 (LG.7F9), anti-CD11b
(M1/70), anti-CD8 (53–6.7), anti-IFN- (XMG1.2), anti-CD19 (1D3),
anti-MHC-II (M5/114.15.2), anti-CD11c (N418), and PE-labeled
streptavidin (SA-PE). For the in vivo cell proliferation assay,micewere i.p.
injected with 2 mg of bromodeoxyuridine (BrdU; Sigma) and sacrificed 3
h later. To detect incorporated BrdU, splenic leukocytes were first stained
for surface antigens and then fixed, permeabilized, refixed, treated with
DNase I, and intracellularly stained according to the manufacturer’s pro-
tocol (BrdUflowkit; BDPharmingen). For the detection of IFN- expres-
sion by NK cells, incubation was performed in RPMI medium supple-
mented with 10% of fetal calf serum (FCS; Gibco) for 5 h in the presence
of 500 IU/ml of interleukin-2 (IL-2) at 37°C with 1 g/ml of brefeldin A
(eBioscience) added for the last 4 h of incubation. For detection of IFN-
expression by CD8 T cells, incubation was performed in RPMImedium
supplemented with 10% of FCS (Gibco) and 1 g of H-2Db-restricted
M45-derived peptide (985HGIRNASFI993), H-2Kb-restricted m139 de-
rived peptide (419TVYGFCLL426), or H-2Kb-restricted M57 derived pep-
tide (816SCLEFWQRV824) for 5 h at 37°C with 1 g/ml of brefeldin A
(eBioscience) added for the last 4 h of incubation (35). Custom MCMV-
specific H-2b class I-restricted antigenic peptide synthesis to a purity of
greater than 80% was performed by Jerini Peptide Technologies. After
incubation, cells were first surface stained and then fixed and permeabil-
ized using Cytofix/Cytoperm solutions (BD Pharmingen) followed by in-
tracellular IFN- staining according to the manufacturer’s protocol. For
DC isolation, splenocytes were digested using collagenase D (Roche)
as described previously (40). Flow cytometry was performed on
FACSCalibur and FASCAria (BDBioscience; San Jose, CA), and datawere
analyzed using the FlowJo software (Tree Star).
Frequencies of IFN--secreting CD8 T cells were determined by an
ELISpot assay essentially as described in greater detail previously (refer-
ence 7 and references therein). Briefly, CD8 T cells were isolated from
lymph node cells by immunomagnetic cell sorting using the autoMACS
system (Miltenyi Biotec Systems, Bergisch Gladbach, Germany) as de-
scribed previously (27), and graded cell numbers in triplicate cultures
were stimulated for 18 h with 105 EL-4 (H-2b) thymoma cells per assay
culture and 106 M synthetic peptides M45, m139, or M57 (see above).
After staining for IFN- and enzymatic color development, frequencies of
responding cells and the corresponding 95% confidence intervals were
determined from the spot counts by intercept-free linear regression anal-
ysis.
Quantification of serum cytokine levels. Serum levels of IFN- were
determined by an enzyme-linked immunosorbent assay (ELISA) kit for
IFN- (PBL Biomedical Laboratories) according to the manufacturer’s
instructions. Serum levels of IL-12, IFN-, IL-6, tumor necrosis factor
alpha (TNF-), IL-15, and IL-10 were determined by the Bio-Rad mouse
cytokine multiplex assay according to the manufacturer’s instructions
(Bio-Rad Laboratories, Hercules, CA).
Statistical analysis. Statistical analysis was carried out using Prism 5
(GraphPad Software, La Jolla, CA). Statistically significant differences be-
tween two data sets in cytokine assays, phenotype analyses, and quantita-
tion of viral transcripts (log-transformed numbers) were determined by
the unpaired two-tailed Student’s t test, and P values of0.05 were con-
sidered significant. Differences in viral titers were determined by two-
tailed Mann-Whitney U test.
RESULTS
Impact of NK cell control on the dynamics of an early antiviral
CD8 T-cell response. MCMV subverts NK cell control by en-
coding four proteins involved in the downmodulation of ligands
for the activating NK cell receptor NKG2D. Specifically, m145,
m152, and m155 interfere with cell surface expression of
MULT-1, of RAE-1 familymembers, and of H60, respectively (19,
30). In addition, m138 simultaneously targets MULT-1, H60, and
RAE-1 (5, 29). However, NK cells can be alternatively engaged by
the viral protein m157, a ligand of the activating NK cell receptor
Ly49H expressed differentially in mouse strains (6, 46). Accord-
ingly, for studying the impact of NK cells on the early CD8T-cell
response, we here used Ly49Hmouse strains capable of mount-
ing an NK cell response regardless of the presence of viral inhibi-
tors of NK cells. The effect of CD8T-cell depletion on virus titers
Mitrovic´ et al.
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in different organs 7 days p.i. in Ly49H and, for comparison, in
Ly49H mice infected with either WT MCMV or mutant virus
lacking them157 gene (m157 virus) was tested (Fig. 1A). On day
7 p.i., in both C57BL/6 and BALB.B6-Cmv1rmice (both Ly49H)
depleted of CD8 T cells, a significant increase of m157 virus
titer was observed, whereas only a minor effect could be seen in
WT infectedmice (Fig. 1A, left). In contrast, in B6.Ly49h/mice,
as well as in BALB/c and 129/SvJ mice (all three Ly49H), the
depletion of CD8 T cells significantly increased the viral titers
irrespective of the virus used (Fig. 1A, right).However, contrary to
the findings on day 7 p.i., the depletion of CD8 T cells did not
notably affect viral titers in organs of C57BL/6mice on day 3.5 p.i.,
thus suggesting that in an early stage of infection CD8 T cells do
not compensate for the absence ofNK cell activity that is caused by
lack of Ly49H activation in Ly49Hmice infectedwith them157
virus (Fig. 1B). This is in agreement with the interpretation that
expression of m152 simultaneously prevents early NK as well as
CD8 T-cell control by downmodulating RAE-1 and MHC-I, re-
spectively (24, 31, 55). Accordingly, at the same time,NK aswell as
CD8 T cells were found to control m152 virus (7). Notably,
although it is well established that MCMV infection within the
salivary glands is controlled primarily by CD4 T cells (22; re-
viewed in reference 9), m157 virus titers in Ly49Hmice as well
as titers for both viruses in Ly49H mice indicated that salivary
gland colonization in the first 7 days is under CD8 T cell control
(Fig. 1A).
Next, we tested whether the differential requirements for
CD8 T cells on day 7 p.i. in control of WT MCMV and m157
virus (Fig. 1A, left) could be explained by a different virus load at
early times when NK cells play a decisive role. To that aim,
C57BL/6 mice were i.v. injected with different doses of WT
MCMV (2 105 PFU, 2 106 PFU, or 4 106 PFU) tomatch the
virus titers inmice that received a single dose ofm157 virus (2
105 PFU). On day 3.5 p.i., only inmice that received 10- to 20-fold
moreWTMCMV, virus titers in organs reached those observed in
mice infectedwith 2 105 PFUofm157 virus (Fig. 2A). Even the
highest dose of WTMCMV failed to reach the titers observed for
m157 virus in the spleen, thus illustrating the robustness of the
Ly49H–m157 pathway in the control of the virus in this organ. In
addition, we tested the requirement for CD8 T cells on day 7 p.i.
inmice that received different doses ofWTMCMVand compared
this to mice injected with only a single dose of m157 virus (Fig.
2B). In agreement with results shown in Fig. 1A, the depletion of
CD8 T cells had only a minor effect on the virus titer in mice
infected with a lower dose of WT MCMV (Fig. 2B). However, by
increasing the dose ofWTMCMV (2 106 PFU or 4 106 PFU),
CD8T cells became increasinglymore important. Yet, the deple-
tion of CD8 T cells inmice infected with a 20-fold higher dose of
WTMCMV still failed to reach the titer found in the spleen of the
CD8 T-cell depleted group infected with 2 105 PFU of m157
virus, thus suggesting that in addition to influencing viral load,
NK cell signaling via Ly49H–m157 interaction may play also a
qualitative role in the regulation of the CD8 T-cell response. To
test this assumption, we performed combined depletion of NK
cells and CD8 T cells in MCMV-infected mice (Fig. 2C). On day
7 p.i. in WTMCMV-infected mice depleted of both NK cells and
CD8 T cells, viral titers in spleen and salivary glands reached
those observed inCD8T-cell depletedmice infectedwithm157
virus. Thus, this result indicates that enhanced CD8 T-cell re-
sponse in mice infected with m157 virus positively correlates
with the virus load.
The impact of Ly49H–m157 interaction on NK cell activa-
tion, maturation, and capacity to control virus replication.
There has been great progress in understanding of how the innate
FIG 1 NK cell-specific recognition of MCMV affects the CD8 T-cell response. (A) Indicated strains of mice were i.v. injected with 2 105 PFU of either WT
or m157MCMV. On days 1 and 5 p.i., mice were i.p. injected with phosphate-buffered saline (PBS) or depleting anti-CD8 MAb. On day 7 p.i., viral titers in
spleens and salivary glands were determined by plaque assay. (B) C57BL/6 mice were i.v. injected with 2 105 PFU of either WT or m157MCMV. On day 1
p.i., mice were i.p. injected with PBS or depleting anti-CD8 MAb. On day 3.5 p.i., viral titers in spleens and lungs were determined by plaque assay. Titers of
individual mice (circles) andmedian values (horizontal bars) are shown. Representative data of at least two independent experiments with three to five mice per
group are shown. Differences are regarded as significant for P values of0.05. Dotted line, detection limit.
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immune response influences adaptive immunity (reviewed in ref-
erence 50). The results presented above suggest that an early
CD8 T-cell response in C57BL/6 mice is shaped by the Ly49H–
m157 interaction. Next, we decided to test whether the enhanced
CD8 T-cell response in C57BL/6 mice infected with m157
MCMV can be related to a differential response of NK cells. In
accordancewith previouswork (8), early virus control in C57BL/6
mice was largely dependent on the Ly49H–m157 interaction. Spe-
cifically, deletion of gene m157 from the virus genome abolished
the antiviral control mediated by NK cells during the first 4 days
p.i. (Fig. 3A). For characterizing the NK cells, C57BL/6 mice were
injected i.v. with 2  105 PFU of the indicated viruses, and NK
cells in the spleen were analyzed for IFN- production, prolifera-
tion, and expression of various markers. A high frequency of
Ly49H IFN- NK cells was observed in mice infected with
m157MCMVcompared toWTMCMV-infectedmice as early as
day 1.5 p.i. (Fig. 3B and C). This difference was present through-
out the observed period. In accordance with the above, the abso-
lute numbers of IFN-NKcells were significantly higher inmice
infectedwithm157 on days 1.5 and 3.5 p.i. (Fig. 3C). Similarly to
IFN-, the expression of the early activation marker CD69 on NK
cells was higher in mice infected with the m157 virus (Fig. 3D).
At first glance, these findings were surprising, as one rather might
have expected lower levels of NK cell activation and IFN- pro-
duction in the absence of Ly49H–m157 signaling. It thus appears
that low viral load after efficient virus control in WT MCMV in-
fection limits the numbers of activated NK cells, possibly due to
generally lower cytokine levels. Contrary to IFN- production,
however, the proliferation of NK cells was significantly high in
mice infected with WTMCMV (13, 16, 26) compared to m157-
infectedmice, indicating a role for Ly49H–m157 signaling in trig-
gering NK cell proliferation (Fig. 3E). This is in line with the ab-
solute numbers of NK cells in the spleen of infectedmice (Fig. 3F).
Specifically, whereas inWTMCMV-infected mice, after an initial
drop, the NK cell number in the spleen returned to the control
level on day 4.5 p.i., in m157-infected mice the numbers of
splenic NK cells remained low. The kinetics of NK cell maturation
was analyzed by the expression of CD27 andCD11bmarkers (17).
The maturation of NK cells, characterized by a high frequency of
NK cells expressing the most mature phenotype CD27low
CD11bhigh, was enhanced inWTMCMV-infected mice (Fig. 3G).
Compared to the situation in WTMCMV-infected mice, the fre-
FIG2 Virus load affects the CD8T-cell-mediated control ofMCMV infection inC57BL/6mice. (A) C57BL/6mice were i.v. injectedwith different doses ofWT
MCMV (2 105 PFU, 2 106 PFU, or 4 106 PFU) or with a single dose of 2 105 PFU ofm157MCMV.On day 3.5 p.i., viral titers in spleens and lungs were
determined by plaque assay. (B) C57BL/6 mice were injected as described above, and on days 1 and 5 p.i. they were i.p. injected with PBS or depleting anti-CD8
MAb.On day 7 p.i., viral titers in spleens were determined by plaque assay. (C) C57BL/6mice were i.v. injectedwith 2 105 PFUof eitherWTorm157MCMV.
Indicated groups were depleted of NK cells, CD8 T cells, or both NK cells and CD8 T cells. On day 7 p.i., viral titers in spleen and salivary glands were
determined by plaque assay. Ø, untreated C57BL/6 mice. Data are compiled from two independent experiments with two to five mice per group. Titers of
individual mice (circles) and median values (horizontal bars) are shown. Dotted line, detection limit.
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quency of CD27low CD11bhigh NK cells was lower on day 4.5 p.i. in
mice infected with m157 MCMV, whereas the frequency of
CD27high CD11bhigh NK cells was higher. By day 7 p.i., the major-
ity of NK cells also had matured to the phenotype CD27low
CD11bhigh, but, compared to WT MCMV-infected mice, a nota-
ble frequency ofNK cells inmice infectedwithm157MCMVstill
remained in the double-positive stage. Thus, these results showed
that Ly49H–m157 signaling drives NK cell proliferation and phe-
notypic maturation, whereas IFN- secretion and CD69 expres-
sion were higher in m157-infected mice, putatively as a conse-
quence of a higher virus load in organs.
Enhanced CD8 T-cell response in mice infected with the
m157 virus. To further evaluate the impact of early NK cell
activation on the CD8 T-cell response, we measured the fre-
quency of IFN- CD8 T cells in MCMV-infected mice upon
stimulation with M45, m139, and M57 peptides in vitro. As early
as on day 4 p.i., we observed a slight increase in the frequency of
CD8 T cells specific for the above-mentioned viral epitopes in
mice infected with m157 virus compared to WT MCMV-
infected mice. The differences were more pronounced on day 7
p.i. for CD8 T cells directed against the epitopesM45 andm139,
whereas no significant differencewas revealed for theM57 epitope
(Fig. 4A). The high frequency of MCMV-specific CD8 T cells in
mice infected with m157 virus, as compared to WT MCMV-
infected mice, was present throughout the observed period of 4
weeks (Fig. 4A). The proliferation capacity of CD8 T cells was
also enhanced on day 7 p.i. in mice infected with m157MCMV,
compared to the WT MCMV-infected group (Fig. 4B). In addi-
tion, on day 4 p.i., the frequency of activatedCD8T cells express-
ing CD69 was significantly higher in mice infected with m157
MCMV (Fig. 4C) and was still somewhat increased on day 7.
We next investigated if the enhanced CD8 T-cell response
against m157 virus is restricted to i.v. infection or applies to
other routes of infection as well. To that aim, the frequencies of
virus-specific CD8 T cells present in the draining popliteal
lymph node (PLN) on day 7 after footpad infection were assessed.
The results shown in Fig. 4D essentially support the results dis-
cussed above for i.v. infection, although the pattern of epitopes
that profit from missing NK cell activation was not absolutely
congruent with that after i.v. infection. However, taking both
routes of infection together, m139 showed consistent results, and
all three epitopes had the potential to profit under either of the
infection routes. One may speculate that epitope-specific differ-
ences depend on the relative contributions of direct antigen pre-
FIG3 Impact of Ly49H–m157 signaling on theNK cell response during earlyMCMV infection. (A)C57BL/6mice, eitherNK cell depletedwith anti-NK1.1MAb
or left undepleted, were i.v. injected with 2 105 PFU of eitherWT orm157MCMV. On days 1.5 and 3.5 p.i., viral titers in spleens were determined by plaque
assay. Titers of individual mice (circles) and median values (horizontal bars) are shown. (B) On days 1.5, 3.5, and 4.5 p.i., splenocytes were assessed for IFN-
production by Ly49H and Ly49H subsets of CD3NK1.1NKcells. (C to F) The absolute numbers of IFN-CD3NK1.1NKcells (C), the percentages
of CD69 CD3 NK1.1 NK cells (D), the absolute numbers of proliferating bromodeoxyuridine-positive (BrdU) CD3 NK1.1 NK cells (E), and the
absolute numbers of CD3NK1.1NK cells (F) in the total spleen cell population at the indicated time points are shown. (G) The maturation pattern of NK
cells on days 1.5, 4.5, and 7 p.i. was determined by expression of cell surface markers CD27 and CD11b. Representative dot plots of splenic NK cells (CD3
NK1.1) from two independent experiments with three or four mice per group are shown. (C to F) Data are presented as means standard error of the mean
(SEM) of at least three mice per group from one of two independent experiments. Asterisks denote significant values as calculated by unpaired, two-tailed
Student’s t test: ns, nonsignificant; , P 0.05; , P 0.01; , P 0.001. Dotted line, detection limit.
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sentation and cross-presentation toCD8T-cell priming and that
this might differ between viral antigenic proteins and routes of
infection.Notably, enhanced priming in the PLN in the absence of
Ly49H–m157 interaction correlated with an elevated intranodal
viral gene expression (Fig. 4E) and thus with a higher viral antigen
load.
Altogether, these results indicate that NK cell activation
through Ly49H–m157 interaction negatively regulates the CD8
T-cell response, which likely relates to a reduced virus replication
and thus a reduced antigen load available for CD8 T-cell
priming.
Secretion of IFN- and other proinflammatory cytokines
correlates with the CD8 T-cell response. A number of studies
emphasized the role of IFN- and other innate cytokines in sup-
porting CD8 T-cell priming through effects on both antigen-
presenting cells and T cells (reviewed in reference 18). It has been
shown previously thatMCMV infection induces high serum levels
of IFN-, IL-12, and IFN- in B6.Ly49h/ mice on day 1.5 p.i.
(15). Based on this finding and in an attempt to explain the en-
hanced CD8 T-cell response in mice infected with m157
MCMV, we assessed the levels of proinflammatory cytokines in
sera of infected mice on days 1.5 and 4 p.i. At the early time point,
the serum level of IFN-was4-fold higher in the group of mice
infectedwithm157 virus than inWTMCMV-infectedmice (Fig.
5). A similar pattern was observed for the other three proinflam-
matory cytokines analyzed, namely, IL-12, IFN-, and IL-6 (Fig.
5). Yet, the level of all four of these cytokines dropped almost
completely by day 4 p.i., suggesting a tight feedback regulation.
Contrary to those of the above-mentioned cytokines, the serum
levels of TNF-were similarly induced with both viruses and only
partially downregulated by day 4. The IL-15 level was elevated on
day 1.5 p.i. withm157 virus, compared toWT infectedmice, but
was strikingly reduced on day 4 p.i. specifically in the group of
mice infected with the m157 virus. Of note is that this correlates
with an impaired NK cell proliferation upon m157 MCMV in-
fection (Fig. 3E). In contrast to proinflammatory cytokines, the
concentration of IL-10 was only modestly upregulated inm157-
infected C57BL/6 mice, but this upregulation lasted until day 4.
These results suggest that an early antiviral response, character-
ized by a high level of proinflammatory cytokines, may be a pa-
rameter in determining the outcome of the CD8T-cell response.
To further evaluate the impact of cytokine-mediated CD8
T-cell response, we analyzed the requirements for CD8 T cells in
control of MCMV infection of B6.IFN/R/ and TNF-
Rp55/ mice. Unlike normal C57BL/6 mice, which control
m157 virus on day 7 p.i. via a CD8 T-cell-dependent mecha-
nism, B6.IFN/R/mice failed to do so, suggesting that type I
IFNs play a role in enhancing CD8 T-cell response. Contrary to
B6.IFN/R/ mice, TNF-Rp55/ mice efficiently controlled
m157 infection by CD8 T cells, indicating that TNF receptor
type I signaling does not contribute to enhanced CD8 T-cell
control of m157 virus (data not shown).
The dynamics of splenicDCs correlates with the level of pro-
inflammatory cytokines. Both the life span and the survival of
DCs in vivo are critical for the priming of the T-cell immune re-
sponse. NK cells cross talk with DCs and thus shape the specific
immune response (reviewed in reference 2). This includes NK cell
killing of immature DCs and the promotion of DCmaturation by
FIG 4 Absence of Ly49H–m157 signaling enhances the CD8 T-cell response in MCMV-infected mice. C57BL/6 mice were infected intravenously (A to C) or
at the left hind footpad (D and E) with 2  105 PFU of either WT or m157 MCMV. (A to D) On the indicated days p.i., splenic leukocytes (A to C) or
immunomagnetically purified CD8 T cells from the draining popliteal lymph node (PLN) (D) were stimulated in culture with the indicated peptides followed
by intracellular IFN- staining in cytofluorometric analysis (A to C) or IFN- secretion in the ELISpot assay (D). (A) The percentages of IFN- CD8 T cells
specific forM45,m139, andM57MCMVpeptides among gated CD3CD8T cells are shown. (B andC) The percentages of proliferating BrdUCD8T cells
(B) andCD69CD8T cells (C) among gatedCD3CD8T cells are shown. (A toC)Data are presented asmeans SEMof at least threemice per group from
one of at least three independent experiments. (D) Immunomagnetically purified CD8 T cells from pools of PLN of five mice per group were stimulated for an
IFN--based ELISpot assay with EL-4 (H-2b) thymoma cells and a saturating concentration (106 M) of synthetic peptides corresponding to the epitopes
indicated. Bars represent frequencies of responding CD8 T cells; error bars indicate the 95% confidence intervals. (E) IE1 transcripts quantitated by RT-qPCR
in draining PLN on day 3 after intraplantar infection. Symbols represent PLN of individual mice with the median value indicated. Throughout, asterisks denote
significance values as calculated by unpaired, two-tailed Student’s t test: ns, nonsignificant; , P 0.05; , P 0.01; , P 0.001.
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NK cell-derived IFN- and TNF-, which can eventually enhance
antigen presentation to T cells (reviewed in reference 52). Con-
versely, DCs are important in NK cell activation and the initiation
of the specific immune response (11). Upon MCMV infection in
vivo, antigen-presenting cells such as conventional dendritic cells
(cDCs), plasmacytoid dendritic cells (pDCs), and macrophages
are key producers of type I IFN and other proinflammatory cyto-
kines (1, 12, 25, 48, 57). However, pDCs seem to play a central role
in mounting a protective type I IFN response (25, 57). In order to
address the impact of DCs on virus susceptibility to NK cell con-
trol and the level of proinflammatory cytokines, we analyzed
splenic cDCs during the early phase of MCMV infection (Fig. 6).
On day 1.5 p.i., we observed no differences in the frequencies of
splenic cDCs (MHC-II CD11c) (Fig. 6A, top) or their CD8
and CD11b subsets (Fig. 6A, bottom) in the comparison be-
tween the two viruses. In addition, at this time point p.i., the
absolute numbers of CD8 (Fig. 6B) andCD11b (Fig. 6C) cDC
subsets were similar between the two infected groups of mice.
However, on day 4 p.i., a dramatic reduction of splenic cDCs was
observed specifically in mice infected with m157 virus, which
may be secondary to the increased level of infection in the absence
of an efficient NK cell control. To determine the extent of cDC
infection, we infected C57BL/6 mice with recombinant WT
MCMV expressing green fluorescent protein (WTMCMV-GFP).
Depletion of NK cells significantly increased the frequency of
MCMV-infected cDCs and CD8 and CD11b cDC subsets on
days 1.5 and 4 p.i. (Fig. 6D). Therefore, although the frequency of
splenic cDCs decreased on day 4 p.i. in mice lacking NK cell con-
trol, the high frequency of infected cDCs among the residual pop-
ulation might explain the improved priming of CD8 T cells. To
conclude, the preservation of cDC subsets on day 1.5 p.i. and the
higher frequency of infected cDCs at early time points p.i., as well
as the higher level of proinflammatory cytokines, might contrib-
ute to the enhanced CD8 T-cell response observed in mice de-
void of Ly49H signaling. In addition, our findings imply that the
reduction of splenic cDCs observed on day 4 p.i. does not com-
promise the CD8 T-cell response.
DISCUSSION
CD8 T cells play a key role in the control of human cytomeg-
alovirus (HCMV) infections (53). Therefore, the understand-
ing of the cellular and molecular mechanisms involved in
priming and shaping of CD8 T-cell response is of high rele-
vance. Both host and viral factors contribute to its nature and
quality (reviewed in reference 28). There exists evidence to
suggest that innate immunity mediated by NK cells is a critical
parameter in determining the strength and quality of the pri-
mary CD8 T-cell response to MCMV (3, 40). MCMV can
activate NK cells by encoding protein m157, a ligand of the
activating NK cell receptor Ly49H. Here we have specifically
investigated the impact of NK cell activation through Ly49H-
m157 signaling on CD8 T-cell priming and antiviral control.
Our results in C57BL/6 mice demonstrated that the require-
ment for CD8 T cells in the virus control during the first week
p.i. is determined by the engagement of the Ly49H receptor and
the capacity of NK cells to control virus replication during the
first 2 days. While CD8 T cells proved to be dispensable for
early virus control in mice infected with WT MCMV, they be-
came essential in mice infected with a virus strain unable to
activate NK cells through the Ly49H receptor, due to deletion
of the ligand-coding gene m157. Moreover, depletion of NK
cells in WT MCMV-infected mice also increased the require-
ments for CD8 T-cell control to a level comparable with the
one observed in mice infected with m157 virus. An enhanced
CD8 T-cell response after infection withm157 virus could at
least in part be explained by a higher antigenic load, as sug-
FIG 5 Impact of Ly49H–m157 signaling on cytokine production during earlyMCMV infection. C57BL/6mice were i.v. injected with 2 105 PFU of eitherWT
or m157MCMV or left uninfected. On days 1.5 and 4 p.i., serum levels of the indicated cytokines were determined. Data are presented as means SEM of at
least three mice per group from one of two independent experiments. Asterisks denote significant values as calculated by unpaired, two-tailed Student’s t test: ,
P 0.05; , P 0.01; , P 0.001., not detected.
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gested previously from a related model of CD8 T-cell priming
to MCMV (7; reviewed in reference 28). Here we provide evi-
dence to conclude that, besides antigenic load, elevated levels
of proinflammatory cytokines and preservation of cDCs at
early times of infection contribute to the enhanced CD8
T-cell response in mice in which the lack of Ly49H–m157 sig-
naling precludes NK cell-dependent early virus control.
Our data show that Ly49H–m157 interaction affects the NK
cell activation pattern early on. NK cell expression of both
IFN- and CD69 were higher in mice that failed to control
virus replication via the Ly49H–m157 pathway (Fig. 3B to D).
This finding also correlates with the level of proinflammatory
cytokines, known to induce CD69 upregulation and IFN-
production by NK cells (14, 36). Although NK cells in mice
infected with m157 virus were stimulated to produce more
IFN- as early as 1.5 days p.i., this was obviously not sufficient
to limit virus replication in the absence of a specific engage-
ment of the Ly49H NK cell receptor. By the same token, NK
cells derived from m157-infected mice failed to proliferate,
thus confirming that a specific engagement of Ly49H receptor
is required for this function (13, 16). This is in accordance with
previous reports showing that ligation of Ly49H receptor to
FIG 6 Ly49H–m157 signaling preserves splenic cDCs during MCMV infection. C57BL/6 mice were i.v. injected with 2  105 PFU of either WT or m157
MCMVor left uninfected.Ondays 1.5 and 4 p.i., splenic leukocytes were stained to assessDC subsets cytofluorometrically. (A) Representative dot plots of splenic
cDCs (CD3CD19MHC-IICD11c) and CD8 and CD11b subsets gated on cDCs are shown. (B and C) The absolute numbers of CD8 cDCs (B) and
CD11b cDCs (C) in total splenic leukocytes are shown. (D) C57BL/6 mice, either NK cell depleted or left undepleted, were i.v. injected with 106 PFU of WT
MCMV-GFP. The frequency of infected splenic cDCs (CD3 CD19MHC-II CD11c GFP) and infected CD8 and CD11b subsets gated on cDCs on
days 1 and 4 p.i. are shown. (B to D) Data are presented as means SEM of at least four mice per group from one of three independent experiments. Asterisks
denote significant values as calculated by unpaired, two-tailed Student’s t test: , P 0.01; , P 0.001.
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m157 is necessary for induction of NK cell proliferation (6, 46).
Furthermore, reduced proliferation capacity of NK cells and
their delayed maturation in mice infected with m157 virus
may also be related to the observed sudden decrease in IL-15
secretion, which was not the case in mice infected with WT
MCMV (Fig. 3E and G and 5).
Although interesting on their own, the different NK cell
maturation and activation patterns in mice infected with WT
MCMV or m157 virus could not directly explain the differ-
ences in the CD8 T-cell response. Several studies have high-
lighted the role of proinflammatory cytokines in the activation
of the cells of the innate and adaptive immune response (37;
reviewed in reference 18). Cytokines produced by NK cells can
prime DCs to produce IL-12 and promote their maturation,
thereby enabling them to become potent antigen-presenting
cells (1; reviewed in references 2 and 56). In addition, IFN-
produced by NK cells promotes antigen processing and presen-
tation to T cells (33; reviewed in reference 39). Here we showed
a dramatic rise in proinflammatory cytokines, including
IFN-, IL-12, IFN-, and IL-6, which may drive a subsequent
CD8 T-cell response. Furthermore, using mice lacking
IFN/ receptor or TNF-Rp55 receptor, we demonstrated that
type I IFNs play a role in enhancing CD8 T-cell response to
the virus unable to activate NK cells, whereas TNF signaling
does not contribute to this function. Elevated levels of proin-
flammatory cytokines on day 1.5 p.i. are in agreement with a
previous finding made in MCMV-infected B6.Ly49h/ mice
(15). The present study also demonstrated a tight regulation of
proinflammatory cytokines, since on day 4 p.i. most of these
were close to the levels observed in control groups. We specu-
late that this tight feedback control is aimed at preventing un-
leashed proliferation of NK cells and CD8 T cells and possibly
also immunopathology. At this time point, the serum levels of
IL-10 were still high, suggesting its role in negative feedback
regulation of immune response (26; reviewed in reference 41).
MCMV infection affects DC maturation, frequently result-
ing in their depletion from the spleen (4). In agreement with
this work, we have shown here that on day 1.5 p.i., cDC subsets
were not affected, irrespective of the virus used, and that a
dramatic drop was observed 4 days p.i. only if the engagement
of the Ly49H receptor wasmissing (4). Interestingly, in another
work, the drop in splenic cDCs in Ly49H mice was observed
already on day 1.5 p.i. (40). These differences might be related
to different mouse strains or the different source of virus used.
In recent work, Stadnisky et al. (47) showed that NK cell acti-
vation by the missing-self mechanism also resulted in faster
recovery of splenic cDCs after their initial drop and in an im-
proved CD8 T-cell response. Thus, the more robust CD8
T-cell response in mice infected with m157 virus looks like a
paradox since it is accompanied by a depletion of splenic cDCs.
This could be explained by a higher level of virus replication
and expression of epitope-encoding viral genes for antigen
cross-presentation in m157 infection, analogous to the model
proposed by Böhm et al., which demonstrated that a virus with
a more efficient replication gives better priming (7; reviewed in
reference 28). Specifically, in that model, WT MCMV was su-
perior to an attenuated immune evasion gene deletion mutant
in the priming of CD8 T cells due to higher replication and
antigen delivery. Our results represent the mirror image of this
model by showing that in C57BL/6 mice, more efficiently rep-
licating m157 virus primes CD8 T cells better than WT
MCMV does. In addition, the frequency of infected cDCs
among residual population on day 4 p.i. was still significantly
higher in mice lacking NK cell control. Thus, it is likely that
these cells might serve as a source for antigen presentation and
cross-presentation. Therefore, we believe that CD8 T-cell re-
sponse is determined by preserved cDCs, higher frequency of
infected cDCs, and high levels of proinflammatory cytokines
during the first 2 days p.i. and that the subsequent reduction of
cDCs has no negative effect on the strength of ongoing CD8
T-cell response. Alternatively, in m157-infected mice, cDCs
might not be physically deleted from the spleen but might
rather be recruited to other sites of infection due to a higher
level of virus replication. It was suggested that the depletion of
cDCs is primarily mediated by NK cell cytotoxicity in a
perforin-dependent manner (3). However, we have found a
dramatic reduction of the splenic cDC pool during an acute
MCMV infection also in mice deficient in perforin (data not
shown), suggesting that the depletion of cDCs is not based on
this cytolytic mechanism.
The impact of NK cells on the subsequent dynamics and the
overall quality of the adaptive immune response may also differ
with respect to the activation signaling pathway in NK cells
involved in the initial virus control. Indeed, in a recent study
we have demonstrated that NK cell activation via the activating
NK cell receptor NKG2D after infection of mice with a recom-
binant virus expressing the NKG2D ligand RAE-1 resulted in
a profound virus attenuation during the first days p.i., yet,
notably, without affecting the magnitude of the MCMV-
specific CD8 T-cell response (45). Challenge experiments
indicated that protection after immunization with RAE-
1MCMV was even superior to the protection observed after
immunization with WT MCMV. Even more striking results
were observed in C57BL/6 mice infected with RAE-1MCMV.
As this virus also expresses the m157 protein, the Ly49H NK
receptor is engaged and controls the virus, which, as shown
here, ought to reduce CD8 T cell priming. Surprisingly, how-
ever, the response was enhanced at early times after infection
with the recombinant virus expressing RAE-1 in addition to
m157. These findings might suggest that different NK cell sig-
naling pathways have different impacts on the subsequent
CD8 T-cell response. Alternatively, enhancement of priming
by expression of an NKG2D ligand on infected cells may in-
volve costimulation by engagement of NKG2D expressed on
CD8 T cells (32).
Collectively, the currently available body of data clearly
demonstrates that the impact of NK cells on the priming of a
CD8 T-cell response depends on the context of infection con-
ditions and a complex set of host and viral factors, arguing
against an easily predictable single mode and fixed direction of
NK cell regulation of the primary CD8 T cell response. This
complexity of parameters and outcomes may explain some of
the apparent discrepancies in the literature.
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